Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome
Gattorno M, Pelagatti MA, Meini A, Obici L, Barcellona R, Federici S, Buoncompagni A, Plebani A, Merlini G, Martini A
Arthritis Rheum · 2008
Grade Ccase seriesn=5
Key Findings
- ●All 5 patients (4 children, 1 adult) had prompt response to anakinra
- ●Symptoms and SAA levels normalised
- ●Disease relapsed within 3-8 days of withdrawal; responded to reintroduction
Referenced in (1 disease)
ID: pmid-18438813DOI: 10.1002/art.23475PMID: 18438813